you are here:

Cadila Healthcare Ltd.

BSE: 532321 | NSE: CADILAHC |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE010B01027 | SECTOR: Pharmaceuticals

BSE Live

May 12, 16:00
646.95 17.25 (2.74%)
Volume
AVERAGE VOLUME
5-Day
868,789
10-Day
809,778
30-Day
726,548
1,388,560
  • Prev. Close

    629.70

  • Open Price

    634.95

  • Bid Price (Qty.)

    646.95 (3647)

  • Offer Price (Qty.)

    649.55 (47)

NSE Live

May 12, 16:00
647.00 17.15 (2.72%)
Volume
AVERAGE VOLUME
5-Day
14,859,725
10-Day
11,745,258
30-Day
12,208,317
29,773,435
  • Prev. Close

    629.85

  • Open Price

    634.95

  • Bid Price (Qty.)

    647.00 (7977)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Yearly Results of Cadila Healthcare (in Rs. Cr.) Mar '20 Mar '19 Mar '18 Mar '17 Mar '16  
Net Sales/Income from operations 5,967.70 5,746.60 5,576.00 3,054.20 6,433.20  
Other Operating Income 379.70 290.80 233.90 176.50 598.80  
Total Income From Operations 6,347.40 6,037.40 5,809.90 3,230.70 7,032.00  
EXPENDITURE  
Consumption of Raw Materials 1,838.30 1,755.80 1,564.00 926.70 1,379.40  
Purchase of Traded Goods 97.90 194.40 318.60 228.80 462.20  
Increase/Decrease in Stocks 15.50 -86.00 -186.90 -147.00 50.20  
Power & Fuel -- -- -- -- --  
Employees Cost 1,077.40 961.20 826.00 620.80 695.80  
Depreciation 428.90 358.20 293.10 250.90 221.20  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,895.20 1,582.20 1,641.90 1,280.30 1,867.80  
P/L Before Other Inc. , Int., Excpt. Items & Tax 994.20 1,271.60 1,353.20 70.20 2,355.40  
Other Income 849.40 559.30 207.90 583.10 174.90  
P/L Before Int., Excpt. Items & Tax 1,843.60 1,830.90 1,561.10 653.30 2,530.30  
Interest 233.90 89.60 63.90 11.10 26.50  
P/L Before Exceptional Items & Tax 1,609.70 1,741.30 1,497.20 642.20 2,503.80  
Exceptional Items -52.00 -- -- -- --  
P/L Before Tax 1,557.70 1,741.30 1,497.20 642.20 2,503.80  
Tax 204.10 301.50 406.40 -19.70 466.30  
P/L After Tax from Ordinary Activities 1,353.60 1,439.80 1,090.80 661.90 2,037.50  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items 59.30 45.90 -- -- --  
Net Profit/(Loss) For the Period 1,412.90 1,485.70 1,090.80 661.90 2,037.50  
Equity Share Capital 102.40 102.40 102.40 102.40 102.40  
Reserves Excluding Revaluation Reserves 11,157.80 8,466.80 7,643.10 6,515.90 6,173.80  
Equity Dividend Rate (%) 350.00 350.00 350.00 320.00 320.00  
EPS Before Extra Ordinary  
Basic EPS 13.80 14.51 10.66 6.47 19.90  
Diluted EPS 13.80 14.51 10.66 6.47 19.90  
EPS After Extra Ordinary  
Basic EPS. 13.80 14.51 10.66 6.47 19.90  
Diluted EPS. 13.80 14.51 10.66 6.47 19.90  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited